Deepinder Goyal’s Temple partners with Art of Living; Why a Japanese entrepreneur sees India as a bridge between rival worlds
Temple will use its new biomarker, Entropy, to track the body’s parasympathetic state during meditation.
Temple technology startup, founded by Deepinder Goyal, has teamed up with the Art of Living foundation for a research project. The collaboration aims to investigate the physiological impacts of various meditation techniques using Temple's proprietary biomarker, Entropy. Deepinder Goyal recently visited the Art of Living foundation to observe the effects of meditation on Entropy.
The results of this study will be disclosed soon. Temple has recently acquired Longevous, a London-based longevity medicine venture, to bolster its clinical and scientific capabilities. Meanwhile, Japanese entrepreneur Naotaka Nishiyama believes that India is serving as a bridge between divided tech ecosystems, offering a neutral diplomatic position, a vast scale, and a highly skilled workforce amidst geopolitical shifts and economic decoupling.
Written by urgent.news from YourStory's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
